Archangels - Making The Future

Associates

Amadeus and Angels Seed Fund

Amadeus and Angels Seed FundArchangel investors have committed £1m to the Amadeus and Angels Seed Fund, which invests in UK based technology opportunities that can revolutionise markets and that need a seed stage investment to prove out the opportunity. With £10m directly under management Amadeus seeks companies with ambitious teams, powerful ideas and a defensible technology or competitive advantage.

Visit Website

Seraphim Capital

Seraphim CapitalSeraphim Capital is a £30m venture capital Fund in which Archangel investors have committed £1m. The Fund's primary focus is on UK centric companies looking for equity capital of between £0.75 million and £2.0 million. The Fund's unique strength is its network of private investors, a national group consisting of some of the UK's most successful and influential business leaders. These are typically CEOs, Chairmen, non-exec directors and successful entrepreneurs who are re-cycling returns from their own enterprises.

Visit Website

Latest News

Powerphotonic - Beam Shaper Optics for Industrial Materials Processing

01 Oct 2014
PowerPhotonic continues to expand its range of beam shaper micro-optics for industrial materials processing. There are options for all laser types including single mode and multi-mode lasers. Designed in UV-fused silica glass, they are ideal for multi kilowatt high power applications. Greater than 95% intensity uniformity can easily be achieved

Airborne Energy in action

20 Sep 2014
Airborne Energy's vertical axis turbines have now been installed on several test sites. Click on the link below to view one in action.

Cable gets to grips with Great British design

25 Jun 2014
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.

MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer

23 Jun 2014
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.

Touch Bionics founder receives Queen’s Honour

16 Jun 2014
David Gow named Commander of the Order of the British Empire Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.